PAINCHEK LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.028 AUD | -3.45% |
|
-3.45% | -24.32% |
| Apr. 23 | PainChek Secures AU$1,210,000 R&D Tax Incentive | MT |
| Mar. 14 | PainChek Establishes Reseller Agreement with UK-Based Nourish Care; Shares Rise 3% | MT |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 46.91 | 181.3 | 119.1 | 66.48 | 34.71 | 32.45 |
| Enterprise Value (EV) 1 | 43.3 | 176.8 | 113 | 55.06 | 28.57 | 29.94 |
| P/E ratio | -9.32 x | -51.4 x | -9.18 x | -10.8 x | -5.52 x | -4.26 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 926 x | 842 x | 401 x | 284 x | 34.9 x | 16.6 x |
| EV / Revenue | 855 x | 820 x | 380 x | 235 x | 28.7 x | 15.3 x |
| EV / EBITDA | -9.01 x | -54.2 x | -9.11 x | -9.05 x | -5 x | -3.96 x |
| EV / FCF | -17.8 x | -94.7 x | 42.1 x | -28.3 x | -5.84 x | -8.68 x |
| FCF Yield | -5.61% | -1.06% | 2.37% | -3.53% | -17.1% | -11.5% |
| Price to Book | 14.5 x | 44 x | 28.9 x | 8.06 x | 6.94 x | 48.6 x |
| Nbr of stocks (in thousands) | 837,635 | 906,659 | 1,035,522 | 1,126,805 | 1,239,773 | 1,297,990 |
| Reference price 2 | 0.0560 | 0.2000 | 0.1150 | 0.0590 | 0.0280 | 0.0250 |
| Announcement Date | 8/27/18 | 8/28/19 | 8/28/20 | 8/30/21 | 8/31/22 | 9/28/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.0506 | 0.2155 | 0.2972 | 0.2339 | 0.9941 | 1.956 |
| EBITDA 1 | -4.806 | -3.259 | -12.4 | -6.082 | -5.716 | -7.568 |
| EBIT 1 | -4.811 | -3.262 | -12.44 | -6.142 | -5.73 | -7.585 |
| Operating Margin | -9,498.16% | -1,514.14% | -4,186.98% | -2,626.02% | -576.41% | -387.78% |
| Earnings before Tax (EBT) 1 | -4.811 | -3.262 | -12.39 | -6.064 | -5.721 | -7.575 |
| Net income 1 | -4.811 | -3.262 | -12.39 | -6.064 | -5.721 | -7.575 |
| Net margin | -9,498.16% | -1,514.14% | -4,170.16% | -2,592.55% | -575.42% | -387.28% |
| EPS 2 | -0.006006 | -0.003891 | -0.0125 | -0.005452 | -0.005070 | -0.005871 |
| Free Cash Flow 1 | -2.427 | -1.866 | 2.681 | -1.945 | -4.889 | -3.448 |
| FCF margin | -4,792.89% | -866.02% | 902.14% | -831.81% | -491.8% | -176.3% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/27/18 | 8/28/19 | 8/28/20 | 8/30/21 | 8/31/22 | 9/28/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 3.61 | 4.56 | 6.12 | 11.4 | 6.14 | 2.51 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -2.43 | -1.87 | 2.68 | -1.95 | -4.89 | -3.45 |
| ROE (net income / shareholders' equity) | -169% | -88.8% | -300% | -98% | -87.6% | -276% |
| ROA (Net income/ Total Assets) | -94.5% | -48.4% | -142% | -42.6% | -38.8% | -100% |
| Assets 1 | 5.09 | 6.738 | 8.737 | 14.24 | 14.75 | 7.548 |
| Book Value Per Share 2 | 0 | 0 | 0 | 0.0100 | 0 | 0 |
| Cash Flow per Share 2 | 0 | 0.0100 | 0.0100 | 0.0100 | 0.0100 | 0 |
| Capex 1 | 0.01 | 0.01 | 0.05 | 0.06 | 0.02 | 0.01 |
| Capex / Sales | 11.59% | 6.73% | 15.33% | 25.67% | 2.21% | 0.7% |
| Announcement Date | 8/27/18 | 8/28/19 | 8/28/20 | 8/30/21 | 8/31/22 | 9/28/23 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.32% | 30.81M | |
| +8.73% | 315B | |
| +21.37% | 210B | |
| +10.09% | 55.7B | |
| +4.40% | 30.86B | |
| -2.00% | 28.19B | |
| +21.02% | 19.08B | |
| +62.80% | 18.15B | |
| +10.13% | 14.31B | |
| -1.28% | 14.48B |
- Stock Market
- Equities
- PCK Stock
- Financials PainChek Limited
